Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

293.74
Delayed Data
As of Sep 04
 -3.70 / -1.24%
Today’s Change
208.64
Today|||52-Week Range
340.34
+14.11%
Year-to-Date

Today’s Trading

Previous close297.44
Today’s open294.36
Day’s range290.14 - 299.87
Volume1,866,471
Average volume (3 months)2,295,696
Market cap$117.1B
Dividend yield--
Data as of 4:02pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+25.23%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book2.79

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk-0.85-1.54%
SNYSanofi-1.12-2.26%
ABBVAbbVie-1.81-2.94%
GSKGlaxoSmithKline-0.93-2.29%
Data as of 4:02pm ET, 09/04/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)$4.23
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers